Skip navigation
Sign up to follow your favorites on all your devices.
Sign up

Ryan Braun case highlights differences between MLB, NFL drug policies

File photo of Brewers Braun celebrating home run against Diamondbacks in their MLB National League Divisional League Series baseball game

Milwaukee Brewers Ryan Braun celebrates hitting a two-run home run against the Arizona Diamondbacks during the first inning in Game 2 of their MLB National League Divisional League Series baseball playoff game in Milwaukee, in this October 2, 2011 file photo. Braun was awarded the National League Most Valuable Player award on November 22, 2011. REUTERS/Pool/Files (UNITED STATES - Tags: SPORT BASEBALL)


New NFL Coaches Association executive director David Cornwell joined PFT Live on Wednesday to talk about his new job.

In his old job, which to a certain extent he’ll continue to do, Cornwell represented players who were appealing penalties imposed for violation of league policies. And he handles not only football players but athletes in other sports.

One of his clients is Ryan Braun, the reigning NL MVP. The appeal of Braun’s 50-game suspension is pending, and I took advantage of the opportunity to pick Cornwell’s brain about Braun’s case.

Though Cornwell wouldn’t say much (OK, anything) about the specific arguments made on Braun’s behalf, Cornwell explained that baseball’s drug-testing program provides multiple possible defenses for players who may have ingested a banned substance unknowingly or for a legitimate reason. For NFL players, none of that matters.